4.6 Article

In vivo Retinal Fluorescence Imaging With Curcumin in an Alzheimer Mouse Model

Journal

FRONTIERS IN NEUROSCIENCE
Volume 14, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fnins.2020.00713

Keywords

amyloid beta; plaques; Alzheimer's Disease; APP; PS1; fluorescence; scanning laser ophthalmoscopy; retinal ganglion cell

Categories

Funding

  1. Brain Canada
  2. Alzheimer Society of Canada (Alzheimer Society Research Program)
  3. Canadian Institute of Health Research

Ask authors/readers for more resources

Alzheimer's disease (AD) is characterized by amyloid beta (A beta) plaques in the brain detectable by highly invasivein vivobrain imaging or in post-mortem tissues. A non-invasive and inexpensive screening method is needed for early diagnosis of asymptomatic AD patients. The shared developmental origin and similarities with the brain make the retina a suitable surrogate tissue to assess A beta load in AD. Using curcumin, a FluoroProbe that binds to A beta, we labeled and measured the retinal fluorescencein vivoand compared with the immunohistochemical measurements of the brain and retinal A beta load in the APP/PS1 mouse model.In vivoretinal images were acquired every 2 months using custom fluorescence scanning laser ophthalmoscopy (fSLO) after tail vein injections of curcumin in individual mice followed longitudinally from ages 5 to 19 months. At the same time points, 1-2 mice from the same cohort were sacrificed and immunohistochemistry was performed on their brain and retinal tissues. Results demonstrated cortical and retinal A beta immunoreactivity were significantly greater in Tg than WT groups. Age-related increase in retinal A beta immunoreactivity was greater in Tg than WT groups. Retinal A beta immunoreactivity was present in the inner retinal layers and consisted of small speck-like extracellular deposits and intracellular labeling in the cytoplasm of a subset of retinal ganglion cells.In vivoretinal fluorescence with curcumin injection was significantly greater in older mice (11-19 months) than younger mice (5-9 months) in both Tg and WT groups.In vivoretinal fluorescence with curcumin injection was significantly greater in Tg than WT in older mice (ages 11-19 months). Finally, and most importantly, the correlation betweenin vivoretinal fluorescence with curcumin injection and A beta immunoreactivity in the cortex was stronger in Tg compared to WT groups. Our data reveal that retina and brain of APP/PS1 Tg mice increasingly express A beta with age.In vivoretinal fluorescence with curcumin correlated strongly with cortical A beta immunohistochemistry in Tg mice. These findings suggest that usingin vivofSLO imaging of AD-susceptible retina may be a useful, non-invasive method of detecting A beta in the retina as a surrogate indicator of A beta load in the brain.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available